Uji klinis Limfedema di Texas
7 studi untuk Limfedema mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
- UT MD Anderson Cancer Center, Houston
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07855627Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989099Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06494111Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
- UTHealth Houston (The University of Texas Health Science Center at Houston), Houston
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07613931Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 2
Semua usia · Wanita · Diperbarui 24 Jul 2026 · NCT06912763A Real-World Registry of Chronic Wounds and Ulcers
- US Wound Registry, The Woodlands
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 16 Jul 2025 · NCT02280733LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
- MD Anderson, Houston
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 11 Mar 2025 · NCT04606030Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.